REGDEV INSIGHTS
RegDev, Inc. and Onyx BioPartners Announce Strategic Partnership to Bring Drug Development Expertise to UAE
RegDev expands to UAE through strategic partnership with Onyx BioPartners and will be at DUPHAT
Read MoreArticle Archive
-
How to Maximize Consultant Engagements
RegDev’s team of consultants are subject matter experts that partner with you to help you achieve your vision and goals. We want you to get the most out of your
Read More >
-
FDA Updates Guidance to Address Medical Misinformation
This revised guidance issued on July 8, 2024, replaces the 2014 draft guidance and is open for public comment for 60 days. Stay informed and help fight the spread of misinformation.
Read More >
-
RegDev Expands into Cybersecurity with New Team Member Rob MacPhee
Rob MacPhee joins the RegDev team as our new cybersecurity expert, bringing his deep knowledge and strategic insights to the life science
Read More >
-
Cancer Trial Eligibility Criteria: New FDA Guidance
The FDA has recently (published April 25, 2024) issued several guidance documents aimed at optimizing cancer trial design and participant selection criteria for clinical trials...
Read More >
